4//SEC Filing
IMPAX LABORATORIES INC 4
Accession 0001437749-15-016546
CIK 0001003642operating
Filed
Aug 26, 8:00 PM ET
Accepted
Aug 27, 7:09 PM ET
Size
10.5 KB
Accession
0001437749-15-016546
Insider Transaction Report
Form 4
MARKBREITER MICHAEL
Director
Transactions
- Exercise/Conversion
Common Stock
2015-08-26$6.55/sh+10,000$65,500→ 18,200 total - Sale
Common Stock
2015-08-25$41.67/sh−9,399$391,656→ 8,200 total - Sale
Common Stock
2015-08-26$42.78/sh−10,000$427,800→ 8,200 total - Exercise/Conversion
Stock Option (Right to Buy)
2015-08-26−10,000→ 0 totalExercise: $6.55Exp: 2019-05-20→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $40.88 to $42.64 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $41.65 to $43.46 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- [F3]100% of the shares subject to the option are fully vested and exercisable.
Documents
Issuer
IMPAX LABORATORIES INC
CIK 0001003642
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001003642
Filing Metadata
- Form type
- 4
- Filed
- Aug 26, 8:00 PM ET
- Accepted
- Aug 27, 7:09 PM ET
- Size
- 10.5 KB